Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer

ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · Published 2026-07-23 · DOI 10.1177/1540658x261467596

Authors (2)

Shabnoor Iqbal, Usman Khan

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Iqbal, S., Khan, U. (2026). Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES. https://doi.org/10.1177/1540658x261467596

Related articles

• Effectiveness and Safety of Immune Checkpoint Inhibitors in Colorectal Cancer: A Systematic Review of Real-World Studies · Current Oncology Reports · 2025 · Cites or is cited by this article
• Identification of Selective Small Molecule Modulators of mRNA Processing Using a Multiplexed QuantiGene High-Throughput Screening Platform · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Neprilysin Inhibitor and Angiotensin Receptor Blocker Attenuate Ischemic Brain Injury: Unveiling the Kinin-Mediated Pathway · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Precision Targeting in Gastric Cancer: AI-Driven Discovery of MET, ADORA2A, CDK5R1, and ADORA1 · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Decoding Cholesterol Metabolic Regulation by Naotai Formula in Stroke Management: An Integrated Network Pharmacology and Mendelian Randomization Approach · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2026 · Same journal
• Letter: New Horizons in Biomarker Discovery: Assay Technologies for Personalized Drug Development · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Advances in Capsaicin-Based Nanocarriers: Bridging Mechanistic Insights with Therapeutic Potential and Clinical Outcomes · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal
• Elucidating Genetic and Immunological Pathways Mediated by Sodium-Glucose Transporter 2 Inhibitors in Reducing Gout Risk: A Two-Step Mendelian Randomization Study · ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES · 2025 · Same journal